Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

RSLS

ReShape Lifesciences (RSLS)

ReShape Lifesciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:RSLS
일자시간출처헤드라인심볼기업
2024/05/1605:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RSLSReShape Lifesciences Inc
2024/05/1605:05GlobeNewswire Inc.ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
2024/05/1421:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
2024/04/0205:05GlobeNewswire Inc.ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
2024/03/2821:31GlobeNewswire Inc.ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
2024/03/0422:31GlobeNewswire Inc.ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
2024/02/2706:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
2024/02/2222:31GlobeNewswire Inc.ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
2024/01/2422:31GlobeNewswire Inc.ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
2024/01/1906:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
2024/01/1708:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RSLSReShape Lifesciences Inc
2024/01/0606:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RSLSReShape Lifesciences Inc
2023/12/2022:31GlobeNewswire Inc.ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership AlternativesNASDAQ:RSLSReShape Lifesciences Inc
2023/12/1306:05GlobeNewswire Inc.ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
2023/11/3006:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
2023/11/2122:06GlobeNewswire Inc.ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross ProceedsNASDAQ:RSLSReShape Lifesciences Inc
2023/11/0906:05GlobeNewswire Inc.ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction PlanNASDAQ:RSLSReShape Lifesciences Inc
2023/11/0622:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
2023/10/1405:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
2023/10/0605:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
2023/10/0322:23Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RSLSReShape Lifesciences Inc
2023/09/3001:30GlobeNewswire Inc.ReShape Lifesciences® Announces Pricing of $3.0 Million Public OfferingNASDAQ:RSLSReShape Lifesciences Inc
2023/09/2806:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:RSLSReShape Lifesciences Inc
2023/09/2305:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
2023/09/2221:31GlobeNewswire Inc.ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVINASDAQ:RSLSReShape Lifesciences Inc
2023/09/2121:31GlobeNewswire Inc.ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
2023/09/1921:31GlobeNewswire Inc.ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
2023/09/1421:31GlobeNewswire Inc.ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ DeviceNASDAQ:RSLSReShape Lifesciences Inc
2023/08/2605:41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:RSLSReShape Lifesciences Inc
2023/08/0806:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RSLSReShape Lifesciences Inc
 검색 관련기사 보기:NASDAQ:RSLS